The hullabaloo the advent of the Human Immuno-deficiency Virus (HIV) that causes Acquired Immune Deficiency Syndrome (AIDS) generated may have petered considerably, but there is no denying the fact that the scourge is still ravaging. With no cure, or effective vaccine in sight yet, dwindling donor funds, and an alleged spike in prevalence at the…

Stakeholders are unanimous that Human Immuno-deficiency Virus (HIV) that causes Acquired Immunodeficiency Syndrome (AIDS), if untreated, has gone from certain death sentences to chronic disease people can live with.

Prevalence of viral Hepatitis B has quadrupled that of Human Immunodeficiency Virus (HIV) in Taraba State, Women and Children Health Empowerment Foundation (WACHEF) has disclosed.

President, World Hepatitis Alliance (WHA), Danjuma Adda, has re-echoed the prevalence of Hepatitis B and C in Nigeria and on the continent in general. He also said that the dreams of achieving the Global Health Sector Strategy (GHSS), would remain a mirage, unless something was done urgently.

In the late 1990s and early 2000s, a new virus (HIV) that caused the devastating disease, AIDs had emerged and spread around the world. The impact of this new virus on people and the economy was only just becoming obvious.

United Nations Joint Action on AIDS (UNAIDS) has said remarkable progress had been made in HIV/AIDS response in Nigeria, with 1.8 million people on treatment.

One of the 21 pregnant girls rescued during a raid on a baby factory by troops of the 14 Army Brigade, Ohafia, Abia State, on Sunday, has tested positive to Human Immuno-deficiency Virus (HIV).

There is a rising cases of children being infected with the Human Immunodeficiency Virus (HIV) in the country due to failure by many pregnant women to register for antenatal services in hospitals, instead patronise traditional birth attendants (TBAs) among other factors fuelling the rate of Child-HIV in the country. CHIJIOKE IREMEKA writes on how the…

Research by Economist Impact across 13 African countries has shown that fully financing the Human Immunodeficiency Virus (HIV) response will save millions of lives and produce substantial health, social and economic gains.

Research and analysis by Economist Impact, conducted across 13 African countries has shown that fully financing the HIV response will save millions of lives and would produce substantial health, social and economic gains and help to end AIDS as a public health threat by 2030. The new report," A Triple Dividend: The health, social and…

Stakeholders have demanded an open license for the generic production of HIV and hepatitis C drugs to allow low and middle-income countries access to lifesaving drugs.

Haematopoietic stem cell transplantation for the treatment of severe blood cancers is the only medical intervention that has cured two people living with Human Immuno-deficiency Virus (HIV) in the past.